Mechanisms of immunopathology in murine models of central nervous system demyelinating disease

Journal of Immunology

Volumn 176, Issue 6, 2006, Pages 3293-3298

  Ercolini, Anne M ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; AXONAL INJURY; BRAIN; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DEMYELINATING DISEASE; DEMYELINATION; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; MOUSE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; VIRUS INFECTION;

EID: 33644836341     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.6.3293     Document Type: Article

References (90)

1. Steinman, L. 1996, Multiple sclerosis; a coordinated immunological attack against myelin in the central nervous system. Cell 85: 299-302.
2. Sun, J. B., T. Olsson, W. Z. Wang, B. G. Xiao, V. Kostulas, S. Fredrikson, H. P. Ekre, and H. Link. 1991. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21: 1461-1468.
3. Ota, K., M. Matsui, E. L. Milford, G. A. Mackin, H. L. Weiner, and D. A. Hafler. 1990. T cell recognition of an immunodominant myelin basic protein epitope in multiple scletosis. Nature 346: 183-187.
4. Bernard, C. C., and N. K. de Rosbo. 1991. Immunopathological recognition of autoantigens in multiple sclerosis. Acta Neurol. 13: 171-178.
5. Gerritse, K., C. Deen, M. Fasbender, R. Ravid, W. Boersma, and E. Claassen. 1994. The involvement of specific anti myelin basic protein antibody- forming cells in multiple sclerosis immunopathology. J. Neuroimmunol. 49: 153-159.
6. Genain, C. P., B. Cannella, S. L. Hauser, and C. S. Raine. 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5: 170-175.
7. Dal Canto, M. C., R. W. Melvold, B. S. Kim, and S. D. Miller. 1995. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection-a pathological and immunological comparison. Microsc. Res. Tech. 32: 215-229.
8. McRae, B. L., M. K. Kennedy, L. J. Tan, M. C. Dal Canto, and S. D. Miller. 1992. Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38: 229-240.
9. Vanderlugt, C. L., and S. D. Miller. 2002. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2: 85-95.
10. Butterfield, R. J., E. P. Blankenhorn, R. J. Roper, J. F. Zachary, R. W. Doerge, J. Sudweeks, J. Rose, and C. Teuscher. 1999. Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/ nonrelapsing EAE are immunogenetically distinct. J. Immunol. 162: 3096-3102.
11. Kira, J., T. Kanai, Y. Nishimura, K. Yamasaki, S. Matsushita, Y. Kawano, K. Hasuo, S. Tobimatsu, and T. Kobayashi. 1996. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann. Neurol. 40: 569-574.
12. Olerup, O., J., Hillert, S. Fredrikson, T. Olsson, S. Kam-Hansen, E. Miller, B. Carlsson, and J. Wallin. 1989. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc. Natl. Acad. Sci. USA 86: 7113-7117.
13. Lehmann, P. V., E. E. Sercarz, T. Forsthuber, C. M. Dayan, and G. Gammon. 1993. Determinant spreading and the dynamics of the autoimmune T cell repertoire. Immunol Today 14: 203-208.
14. McRae, B. L., C. L. Vanderlugr, M. C. Dal Canto, and S. D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182: 75-85.
15. McMahon, E. J., S. L. Bailey, C. V. Castenada, H. Waldner, and S. D. Miller. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11: 335-339.
16. Vanderlugt, C. L., T. N. Eagar, K. L. Neville, K. M. Nikcevich, J. A. Bluestone, and S. D. Miller. 2000. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J. Immunol. 164: 670-678.
17. Yu, M., J. M. Johnson, and V. K. Tuohy. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183: 1777-1788.
18. Jones, R. E., D. Bourdette, N. Moes, A. Vandenbark, A. Zamora, and H. Offner. 2003. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelids. J. Immunol. 170: 1690-1698.
19. Ellmerich, S., K. Takacs, M. Mycko, H. Waldner, F. Wahid, R. J. Boyton, P. A. Smith, S. Amor, D. Baker, D. A. Hafler, et al. 2004. Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis. Eur. J. Immunol. 34: 1839-1848.
20. Klehmet, J., C. Shive, R. Guardia-Wolff, I. Petersen, E. G. Spack, B. O. Boehm, R. Weissert, and T. G. Forsthuber. 2004. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis. Clin. Immunol. 111: 53-60.
21. Davies, S., T. Nicholson, M. Laura, G. Giovannoni, and D. M. Altmann. 2005. Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosis. J. Neuropathol. Exp. Neurol. 64: 371-377.
22. Goebels, N., H. Hofstetter, S. Schmidt, C. Brunner, H. Wekerle, and R. Hohlfeld. 2000. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain 123: 508-518.
23. Muraro, P. A., K. P. Wandinger, B. Bielekova, B. Gran, A. Marques, U. Utz, H. F. McFarland, S. Jacobson, and R. Martin. 2003. Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders. Brain 126: 20-31.
24. Kurtzke, J. F. 1993. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6: 382-427.
25. Kurtzke, J. F. 2000. Multiple sclerosis in time and space-geographic clues to cause. J. Neurovirol. 6 (Suppl. 2): S134-S140.
26. Kurtzke, J. F., C. S. Raine, H. F. McFarlin, and W. W. Tourtellotte. 1997. The epidemiology of multiple sclerosis. In Multiple Sclerosis: Clinical and Pathogenetic Basis. Chapman and Hall, London, pp. 91-139.
27. Edwards, S., M. Zvartau, H. Clarke, W. Irving, and L. D. Blumhardt. 1998. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 64: 736-741.
28. Andersen, O., P. E. Lygner, T. Bergsttom, M. Andersson, and A. Vahlne. 1993. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J. Neurol. 240: 417-422.
29. Challoner, P. B., K. T. Smith, J. D. Parker, D. L. MacLeod, S. N. Coulter, T. M. Rose, E. R. Shultz, J. L. Bennett, R. L. Garber, M. Chang, et al. 1995. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. USA 92: 7440-7444.
30. Sriram, S., C. W. Stratton, S. Yao, A. Tharp, L. Ding, J. D. Bannan, and W. M. Mitchell. 1999. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann. Neurol. 46: 6-14.
31. Oleszak, E. L., J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas. 2004. Theiler's virus infection: a model for multiple sclerosis. Clin. Microbiol. Rev. 17: 174-207.
32. Kim, B. S., and J. P. Palna. 1999. Immune mechanisms of Theiler's virus-induced demyelination, Exp. Mol. Med. 31: 15-121.
33. Olson, J. K., J. L. Croxford, and S. D. Miller. 2001. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T cell-mediated autoimmune diseases. Viral Immunol. 14: 227-250.
34. Dal Canto, M. C., and H. L. Lipton. 1982. Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am. J. Pathol. 106: 20-29.
35. Lipton, H. L., G. Twaddle, and M. L. Jelachich. 1995. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69: 2525-2533.
36. Trottier, M., P. Kallio, W. Wang, and H. L. Lipton. 2001. High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus. J. Virol. 75: 7420-7428.
37. Miller, S. D., C. L. Vanderlugt, W. S. Begolka, W. Pao, R. L. Yauch, K. L. Neville, Y. Katz-Levy, A. Carrizosa, and B. S. Kim. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3: 1133-1136.
38. Barbano, R. L., and M. C. Dal Canto. 1984. Serum and cells from Theiler's virus-infected mice fail to injure myelinating cultures or to produce in vivo transfer of disease: the pathogenesis of Theiler's virus-induced demyelination appears to differ from that of EAE. J. Neurol. Sci. 66: 283-293.
39. Miller, S. D., R. J. Clatch, D. C. Pevear, J. L. Trotter, and H. L. Lipton. 1987. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. J. Immunol. 138: 3776-3784.
40. Clatch, R. J., H. L. Lipton, and S. D. Miller. 1986. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 136: 920-927.
41. Neville, K. L., J. Padilla, and S. D. Miller. 2002. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: Implications for the treatment of MS. J. Neuroimmunol. 123: 18-29.
42. Katz-Levy, Y., K. L. Neville, J. Padilla, S. M. Rahbe, W. S. Begolka, A. M. Girvin, J. K. Olson, C. L. Vanderlugt, and S. D. Miller. 2000. Temporal development of autoreactive Th1 responses and endogenous antigen presentation of self-myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J. Immunol. 165: 5304-5314.
43. Allegretta, M., J. A. Nicklas, S. Sriram, and R. J. Albertini. 1990. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247: 718-721.
44. Wucherpfennig, K. W., J. Zhang, C. Witek, M. Matsui, Y. Modabber, K. Ota, and D. Hafler. 1994. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 152: 5581-5592.
45. Zhang, J., and J. Raus. 1994. Myelin basic protein-reactive T cells in multiple sclerosis: pathologic relevance and therapeutic targeting. Cytotechnology 16: 181-187.
46. Hausmann, S., M. Martin, L. Gauthier, and K. W. Wucherpfennig. 1999. Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition. J. Immunol. 162: 338-344.
47. Wucherpfennig, K. W., and J. L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695-705.
48. Grogan, J. L., A. Kramer, A. Nogai, L. Dong, M. Ohde, J. Schneider-Mergener, and T. Kamradt. 1999. Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice. J. Immunol. 163: 3764-3770.
49. Ufret-Vincenty, R. L., L. Quigley, N. Tresser, S. H. Pak, A. Gado, S. Hausmann, K. W. Wucherpfennig, and S. Brocke. 1998. In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis. J. Exp. Med. 188: 1725-1738.
50. Barnett, L. A., J. L. Whitton, Y. Wada, and R. S. Fujinami. 1993. Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J. Neuroimmunol. 44: 15-25.
51. Olson, J. K., J. L. Croxford, M. Calenoff, M. C. Dal Canto, and S. D. Miller. 2001. A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest. 108: 311-318.
52. Carrizosa, A. M., L. B. Nicholson, M. Farzan, S. Southwood, A. Sette, R. A. Sobel, and V. K. Kuchroo. 1998. Expansion by self antigen is necessary for the induction of experimentai autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen. J. Immunol. 161: 3307-3314.
53. Croxford, J. L., H. A. Anger, and S. D. Miller. 2005. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry. J. Immunol. 174: 907-917.
54. Ctoxford, J. L., J. K. Olson, H. A. Anger, and S. D. Miller. 2005. Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis. J. Virol. 79: 8581-8590.
55. Matthews, A. E., S. R. Weiss, and Y. Paterson. 2002. Murine hepatitis virus-a model for virus-induced CNS demyelination. J. Neurovirol. 8: 76-85.
56. Knobler, R. L., P. W. Lampert, and M. B. Oldstone. 1982. Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature 298: 279-280.
57. Lavi, E., D. H. Gilden, Z. Wroblewska, L. B. Rorke, and S. R. Weiss. 1984. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 34: 597-603.
58. Wang, F. I., D. R. Hinton, W. Gilmore, M. D. Trousdale, and J. O. Fleming. 1992. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab. Invest. 66: 744-754.
59. Takahashi, K., N. Goto, Y. Matsubara, and K. Fujiwara. 1987. Postinflammatoty remyelination in the spinal cord of mice infected with mouse hepatitis virus, JHM strain. Jpn. J. Exp. Med. 57: 145-151.
60. Erlich, S. S., J. O. Fleming, S. A. Stohlman, and L. P. Weiner. 1987. Experimental neuropathology of chronic demyelination induced by a JHM virus variant (DS). Arch. Neurol. 44: 839-842.
61. Powell, H. C., and P. W. Lampert. 1975. Oligodendrocytes and their myelin-plasma membrane connections in JHM mouse hepatitis virus encephalomyelitis. Lab. Invest. 33: 440-445.
62. Lampert, P. W., J. K. Sims, and A. J. Kniazeff. 1973. Mechanism of demyelination in JHM virus encephalomyelitis: electron microscopic studies. Acta Neuropathol. (Berl.) 24: 76-85.
63. van Berlo, M. F., R. Warringa, G. Wolswijk, and M. Lopes-Cardozo. 1989. Vulnerability of rat and mouse brain cells to murine hepatitis virus (JHM-strain): studies in vivo and in vitro. Glia 2: 85-93.
64. Barac-Latas, V., G. Suchanek, H. Breitschopf, A. Stuehler, H. Wege, and H. Lassmann. 1997. Patterns of oligodendrocyte pathology in coronavirus-induced subacute demyelinating encephalomyelitis in the Lewis rat. Glia 19: 1-12.
65. + cells to demyelination induced by coronavirus JHM. Reg. Immunol. 5: 37-43.
66. Wu, G. F., and S. Perlman. 1999. Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropiccoronavirus. J. Virol. 73: 8771-8780.
67. Glass, W. G., M. T. Liu, W. A. Kuziel, and T. E. Lane. 2001. Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus. Virology 288: 8-17.
68. + T cells. Microb. Pathog. 18: 211-221.
69. 2-microglobulin knockout mice. Pathobiology 67: 75-83.
70. Houtman, J. J., and J. O. Fleming. 1996. Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected wich murine coronavirus JHM. J. Neurovirol. 2: 101-110.
71. Wu, G. F., A. A. Dandekar, L. Pewe, and S. Perlman. 2000. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J. Immunol. 165: 2278-2286.
72. + T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J. Virol. 74: 1415-1424.
73. Stohlman, S. A., and D. R. Hinton. 2001. Viral induced demyelination. Brain Pathol. 11: 92-106.
74. Fazaketley, J. K., S. Pathak, M. Scallan, S. Amor, and H. Dyson. 1993. Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons. Virology 195: 627-637.
75. Balluz, I. M., G. M. Glasgow, H. M. Killen, M. J. Mabtuk, B. J. Sheahan, and G. J. Atkins. 1993. Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage. Neuropathol. Appl. Neurobiol. 19: 233-239.
76. Amor, S., M. F. Scallan, M. M. Morris, H. Dyson, and J. K. Fazakerley. 1996. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. J. Gen. Virol. 77: 281-291.
77. Mokhtarian, F., and P. Swoveland. 1987. Predisposition to EAE induction in resistant mice by priot infection with Semliki Forest virus. J. Immunoi. 138: 3264-3268.
78. McDonald, W. I., A. Compston, G. Edan, D. Goodkin, H. P. Hartung, F. D. Lublin, H. F. McFarland, D. W. Paty, C. H. Polman, S. C. Reingold, et al. 2001. Recommended diagnostic ctiteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50: 121-127.
79. Fazakerley, J. K., S. Amor, and H. E. Webb. 1983. Reconstitution of Semliki forest vitus infected mice, induces immune mediated pathological changes in the CNS. Clin. Exp. Immunol. 52: 115-120.
80. + T cells prevents lesions of demyelination in Semliki Forest virus infection. J. Virol. 67: 7629-7633.
81. Keogh, B., G. J. Atkins, K. H. Mills, and B. J. Sheahan. 2002. Avirulenc Semliki Forest virus replication and pathology in the central nervous system is enhanced in IL-12-defective and reduced in IL-4-defective mice: a role for Th1 cells in the protective immunity. J. Neuroimmunol. 125: 15-22.
82. Keogh, B., G. J. Atkins, K. H. Mills, and B. J. Sheahan. 2003. Role of interferon-γ and nitric oxide in the neuroparhogenesis of avirulent Semliki Forest virus infection. Neuropathol. Appl. Neurobiol. 29: 553-562.
83. Butt, A. M., M. G. Tutton, S. L. Kirvell, S. Amor, and H. G. Jenkins. 1996. Morphology of oligodendrocytes during demyelination in optic nerves of mice infected with Semliki Forest virus. Neuropathol. Appl. Neurobiol. 22: 540-547.
84. Mokhtarian, F., Y. Shi, P. F. Zhu, and D. Grob. 1994. Immune responses, and autoimmune outcome, during virus infection of the central nervous system. Cell. Immunol. 157: 195-210.
85. Smith-Norowitz, T. A., R. A. Sobel, and F. Mokhtarian. 2000. B cells and antibodies in the pathogenesis of myelin injury in Semliki Forest virus encephalomyelitis. Cell. Immunol. 200: 27-35.
86. Mokhtarian, F., Z. Zhang, Y. Shi, E. Gonzales, and R. A. Sobel. 1999. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J. Neuroimmunol. 95: 43-54.
87. McFarland, H. F., D. E. Griffin, and R. T. Johnson. 1972. Specificity of the inflammatory response in viral encephalitis. I. Adoptive immunization of immunosuppressed mice infected with Sindbis virus. J. Exp. Med. 136: 216-226.
88. Mokhtarian, F., D. Grob, and D. E. Griffin. 1989. Role of the immune response in Sindbis virus-induced paralysis of SJL/J mice. J. Immunol. 143: 633-637.
89. + T cells. J. Immunol. 162: 1624-1632.
90. Irani, D. N. 1998. The susceptibility of mice to immune-mediated neurologic disease correlates with the degree to which their lymphocytes resist the effects of brain-derived gangliosides. J. Immunol. 161: 2746-2752.